Approval · Notice of Compliance 17617 · 2015
MENVEO: Notice of Compliance 17617
Issued December 22, 2015
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 17617
- Date
- December 22, 2015
- Company
- Glaxosmithkline IncMississauga, Ontario, Canada
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Transfer of drug identification number
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| MENVEO | Not yet assigned | — |
Medicinal ingredients
- CORYNEBACTERIUM DIPHTHERIAE CRM-197 PROTEIN 47 MCG per 0.5ML
- MENINGOCOCCAL GROUP A OLIGOSACCHARIDE 10 MCG per 0.5ML
- MENINGOCOCCAL GROUP C OLIGOSACCHARIDE 5 MCG per 0.5ML
- MENINGOCOCCAL GROUP W-135 OLIGOSACCHARIDE 5 MCG per 0.5ML
- MENINGOCOCCAL GROUP Y OLIGOSACCHARIDE 5 MCG per 0.5ML